PLoS OnePLoS ONEplosplosonePLoS ONE1932-6203Public Library of ScienceSan Francisco, USA239911783753262PONE-D-13-1081410.1371/journal.pone.0073158Research ArticlePolymorphism in the Hypoxia-Inducible Factor 1alpha Gene May Confer Susceptibility to LDD in Chinese CohortHIF-1α Polymorphism and Susceptibility to LDDLinWen-Ping1WangXue-Jin2WangCong-Ren3ZhangLi-Qun4LiNeng5WangFa-Sheng4LinJian-Hua4*Department of Orthopedic Surgery, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, Fujian Province, People’s Republic of ChinaDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, Fujian Province, People’s Republic of ChinaDepartment of Oncosurgery, Affiliated Quanzhou First Hospital, Fujian Medical University, Quanzhou, Fujian Province, People’s Republic of ChinaDepartment of Orthopedic Surgery, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian Province, People’s Republic of ChinaDepartment of Pathogeny Biology, College of Preclinical Medicine, Fujian Medical University, Fuzhou, Fujian Province, People’s Republic of ChinaKhudyakovYury EEditorCenters for Disease Control and Prevention, United States of America* E-mail: jianhua0918@126.com

Competing Interests: The authors have declared that no competing interests exist.

Conceived and designed the experiments: WPL XJW JHL. Performed the experiments: CRW LQZ. Analyzed the data: NL FSW JHL. Wrote the manuscript: WPL XJW JHL.

2013268201388e73158133201317720132013Lin et alThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Objective

This study aimed to investigate whether or not hypoxia-inducible factor-1α (HIF-1α) gene variants are associated with the susceptibility and clinical characteristics of lumbar disc degeneration (LDD).

Methods

We examined 320 patients with LDD and 447 gender- and age-matched control subjects. We also determined the HIF-1α gene variants, including C1772T (P582S) and G1790A (A588T) polymorphisms.

Results

Significant differences were observed in allelic and genotypic distributions of 1790 A > G polymorphisms between LDD cases and control subjects. Logistic regression revealed that 1790 AA genotypes indicated a protective effect against the development of LDD. The HIF-1α 1790 A > G polymorphisms also affected the severity of LDD as evaluated based on the modified Japanese Orthopedic Association (mJOA) scores. The 1790 AA genotype carriers exhibited significantly lower mJOA scores than AG and GG carriers. C1772T did not show any association with the risk and severity of LDD.

Conclusion

Our study suggested that HIF-1α 1790 A > G polymorphisms may be used as a molecular marker to determine the susceptibility and severity of LDD.

This study was supported by a grant from the Scientific Research Project of Department of Public Health of Fujian Province, China in 2012 (Grant No. 2012-2-56). The URL of the funder's website is http://www.fjphb.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Introduction

Lumbar disc degeneration (LDD) is a major cause of disability and has been associated with low back pain [1–4]. LDD is caused by various intrinsic and extrinsic factors; however, the etiology of LDD remains poorly understood. Environmental factors such as age, gender, smoking habits, overweight, and exposure to vibration may contribute to LDD [3,5–7]. Studies have also revealed that the genetic background may contribute to the development of LDD [8,9].

The lumbar disc tissue is avascular, although small discrete capillary beds are found in the dorsal and ventral surfaces. For this reason, nucleus pulposus cells commonly reside in a hypoxic environment [10]. The functions of hypoxia-inducible factor-1α (HIF-1α) and other factors associated with hypoxia in the mechanism of LDD development has also been reported [11].

HIF-1α functions as a key regulator of cellular responses to hypoxia and other processes, including angiogenesis, erythropoiesis, energy metabolism, vasomotor function, and apoptotic/proliferative responses [12–14]. HIF-1α is expressed in nucleus pulposus cells and has an important function in regulating energy metabolism and matrix synthesis [15–17]. Another study has revealed that HIF-1α may function in the survival of disc cells and the resorption of the herniated disc in human intervertebral discs [18].

HIF-1α expression is regulated by gene polymorphism. In the HIF-1α gene, two polymorphisms, namely, C1772T (P582S) and G1790A (A588T) polymorphisms significantly increase gene transcriptional activity; these polymorphisms are correlated with the increased expression of proteins compared with the wild-type sequence HIF-1α C1772T polymorphism, thereby leading to HIF-1α mRNA overexpression in patients with prostate cancer [19,20].

Although HIF-1α expression has been observed in nucleus pulposus cells, the function of HIF-1α gene polymorphisms in LDD remains unknown. We postulated that the HIF-1α gene variants may be related to the risk of LDD. In the present study, the patients with LDD and the healthy control subjects were enrolled to investigate whether or not HIF-1α gene variants are associated with the susceptibility and clinical characteristics of LDD.

Materials and MethodsEthics statement

This study was approved by the Ethical Committee of Fujian Medical University (No. 2012-2-56). All of the participants provided their written informed consent to participate in this study.

Subject Enrollment

We examined 320 patients with LDD and 447 gender- and age-matched control subjects from September 2008 to August 2012 in the affiliated hospital of our school. All of the patients received MRI evaluation, and all of the control subjects were evaluated by CT or MRI. The diagnosis of LDD was confirmed by two orthopedic surgeons specializing in spinal diseases, but these surgeons were unaware of the study design. The disc degeneration grade was determined according to Schneiderman’s classification of MRI [21]. The exclusion criteria were listed as follows: a) subject with autoimmune and inflammatory diseases; b) severe degenerative disc disease with a collapsed intervertebral space; c) previous surgical treatment in the lumbar spine; d) severe osteoporosis; and e) segmental instability. The severity of LDD was evaluated based on the modified Japanese Orthopedic Association (mJOA) scoring system [22]. The following data were collected from the participants: gender; age; body mass index (BMI); smoking status; and family history of LDD.

HIF-1α genotyping

Genomic DNA was isolated from the peripheral blood leukocytes according to standard protocols. Polymerase chain reaction (PCR) was performed to amplify the 178 bp fragment of exon 12 in the HIF-1α human gene by using 5ʹ-CAT GTA TTT GCT GTT TTA AAG-3ʹ as the forward primer and 5ʹ-GAG TCT GCT GGA ATA CTG TAA CTG-3ʹ as the reverse primer. The mixture (30 µL) used for PCR contained 200 ng of the template DNA, 0.2 mM of each dNTP, 0.5 µM of each forward and reverse primer, 1.5 mM of MgCl2, 0.5 U of Taq polymerase, and 3 µL of 10× PCR buffer. The PCR conditions were listed as follows: denaturation at 95 °C for 5 min; 35 cycles of denaturation at 95 °C for 30 s; annealing at 61 °C for 30 s; extension at 70 °C for 1 min; and a final extension at 72 °C for 10 min. The PCR products were purified and sequenced using the Big Dye Terminator kit (version 3.1) on an ABI Prism® 3100 Automated DNA sequencer according to the manufacturer’s protocol (Applied Biosystems, Foster City, CA).

HIF-1α and VEGF Western blot

A total of 134 herniated lumbar intervertebral discs were collected during surgery from the patients with LDD and who underwent surgical treatment. The samples (0.3 g to 0.5 g) were homogenized and lysed. The extracts were resolved on sodium dodecyl sulfate (SDS)-polyacrylamide gels and then transferred to nitrocellulose membranes (BioRad). The proteins were also resolved by electrophoresis on 8% to 12% SDS-polyacrylamide gels and then transferred to polyvinylidene difluoride membranes (Bio-Rad) by electroblot. The membranes were blocked with 5% non-fat dry milk in TBST (50 mM Tris, pH 7.6, 150 mM NaCl, and 0.1% Tween 20) and incubated overnight at 4 °C in 3% non-fat dry milk in TBST with anti-Hsp70 (Stressgen, 1:4000), anti-HIF-1α (Novus Biological, 1;1000), VEGF (Santa Cruz,1:1000), and anti-GAPDH (Santa Cruz, 1:2000) antibodies. Immunolabeling was detected using an ECL reagent (Amersham Biosciences).

Statistical analysis

For each SNP, a chi-square test was performed to assess Hardy-Weinberg equilibrium and the association between the LDD cases and the control groups based on allelic and genotypic frequencies. The characteristics of the LDD subjects and the control subjects were compared by performing chi-square or Student’s t-test according to the variable types. Binary logistic regression test was performed to determine the risk factor of LDD. The odds ratios (OR) and 95% confidence intervals (CIs) were calculated by adjusting age, gender, smoking status, and other clinical data. Results were considered significantly different at P < 0.05. The Raytest TINA software (http://www.raytest.de/service/raytest_catalog.html) was used for western blot to perform densitometric analysis and evaluate the expressions of HIF-1α and VEGF as described previously [23]. Differences in the relative expressions among different genotypes were compared by ANOVA in SPSS software (Statistical Package for the Social Sciences, version 16.0, SPSS Inc., Chicago, IL, USA).

ResultsCharacteristics of the cases and the control subjects

Table 1 shows the demographic characteristics of the LDD subjects and the control subjects. Gender, age, and BMI were similar between the two groups. Smokers were more common in the LDD subjects than in the control subjects (39.2% vs. 23.3%, P = 0.041). The patients with LDD exhibited a higher percentage of DM than the control subjects (P = 0.033). The incidence of positive family history was markedly higher in the LDD group than in the control group (18.3% vs. 8.3%, P < 0.001).

Characteristics of subjects.
VariablesCase n=320Control n=447P
Age(mean ± SD)47.1 ± 7.247.0± 6.80.584
Gender (Male, %)154 (48.1%)213 (47.6%)0.743
BMI(mean ± SD)23.7 ± 3.523.5 ± 2.70.772
Smoking (%)125 (39.1%)104 (23.3%)0.041
Family history (%)58 (18.4%)47 (8.3%)< 0.001
History of labor work (%)120 (37.5%)51 (11.4%)< 0.001
DM62 (19.4%)45 (10.1%)0.0033

Table 2 summarizes the allelic frequencies and genotypic distributions of the SNPs in the LDD cases and the control subjects. The genotypic distributions of each SNP were consistent with Hardy-Weinberg equilibrium (P > 0.05). For SNPs at 1772 C > T, no statistically significant difference was observed in the distribution of the alleles and genotypes among the patients and the control subjects (P = 0.982 and P = 0.482, respectively). For SNPs at 1790 G > A, the AA prevalence was markedly lower in the LDD cases than in the control subjects (20.80% vs. 52.49%, P = 0.001). Allele analysis revealed that the A allele frequencies were 43.25% and 48.5% in the patients with LDD and the control subjects, respectively (P = 0.001). Using GG as the reference, we conducted multivariate logistic regression analysis and found that the AA genotype carriers exhibited lower risks of developing LDD (adjusted OR = 2.15, 95% CI = 1.30–3.11, adjusted P = 0.002), in which age, gender, BMI, smoking status, family history, history of labor, and DM were adjusted.

The genotype and allele distribution of HIF-1α gene SNPs in LDD cases and controls.
LDDControl
N%N%global Padjusted OR95%CIadjusted P
1772CC9032.85%10133.55%0.9821
1772CT14352.19%15651.83%1.030.721.480.88
1772TT4114.96%4414.62%1.050.631.740.86
C32358.94%35859.47%0.4521
T22541.06%24440.53%1.020.811.290.86
1790GG9434.31%7625.25%0.0111
1790GA12344.89%13444.52%0.740.51.10.13
1790AA5720.80%9130.23%0.510.320.79P<0.001
G31156.75%28647.51%0.0011
A23743.25%31652.49%0.690.550.87P<0.001

We analyzed the association of HIF-1α SNPs and the severity of LDD in the LDD subjects. The severity of LDD was stratified according to HIF-1α genotypes. Figure 1 shows that the severity of LDD was similar in the subjects with 1772 C > T genotype (P > 0.05). However, the severity of LDD in the subjects with 1790 A > G genotype were significantly different. The genotype carriers of 1790 AA exhibited significantly lower mJOA scores (9.6±0.2) than AG and GG carriers (11.7±0.2 and 12.0±0.3, respectively).

10.1371/journal.pone.0073158.g001HIF-1α SNPs and the LDD severity within LDD subjects.

We compared HIF-1α and VEGF protein expressions in the samples obtained from the patients with LDD. The Characteristics and genotype distribution for 134 subjects selected for western blot were shown in Table S1 and Table S2. The herniated lumbar intervertebral discs collected from the patients with LDD exhibiting different genotypes underwent surgical treatment. Figure 2 shows the typical bands of the samples from the patients with LDD. We detected the HIF-1α protein expression by western blot analyses. Our results showed that the 1790 A > G SNPs significantly affected HIF-1α and VEGF expressions. The HIF-1α and VEGF protein expressions were significantly lower in 1790 AA carriers than in 1790 AG and 1790 GG carriers. VEGF expression was lower in 1790 AA carriers than in 1790 AG and 1790 GG carriers. By contrast, 1772 C > T genotype did not exhibit any change in HIF-1α and VEGF protein expressions. Quantitative analyses by Raytest TINA software showed that the relative protein expressions of VEGF were 0.33±0.03, 0.40±0.07, and 0.88±0.06 in 1790 AA, 1790 GA, and 1790 GG carriers, respectively (P < 0.001, Figure 3a). The relative expressions of HIF-1α were 0.25±0.01, 0.26±0.02, and 0.43±0.03 in 1790 AA, 1790 GA, and 1790 GG carriers, respectively (P < 0.001, Figure 3b). These results indicated that the relative expressions of VEGF and HIF-1α were not affected by 1172 C > T genotypes.

10.1371/journal.pone.0073158.g002HIF-1α and VEGF protein expression in samples from LDD patients.10.1371/journal.pone.0073158.g003The VEGF and HIF-1α relative expressions by 1790G>A genotypes.Discussion

As the largest avascular tissue in the human body, the nucleus pulposus contains cells that are morphologically similar to cartilage cells. The nucleus pulposus is an aggrecan-rich avascular tissue that permits the intervertebral disc to resist compressive loads. The metabolism of such cells is performed by capillary diffusion from the end plate of the cartilage found in their vicinity [24]. HIF-1α is widely expressed in almost all cells in the human body; HIF-1α is also a molecule that detects oxygen stress and cell responses. HIF-1α is degraded under normal oxygen stress and undergoes ubiquitination. However, degradation is suppressed when the cells are exposed to hypoxic condition; as a result, HIF-1α is amplified rapidly and accumulates in cells [25].

An in vitro study showed that the oxygen-independent stabilization of HIF-1α in nucleus pulposus cells is a metabolic adaptation that initiates glycolysis and aggrecan expression [16]. Another study has shown HIF-1α expression in the intervertebral disc cells, in which HIF-1α also regulates the apoptosis of intervertebral disc cells, suggesting that HIF-1α is involved in the homeostasis of intervertebral disc cells [26].

The HIF-1α gene is located at chromosome 14q21–q24. In vitro studies have demonstrated that the C1772T (P582S) and G1790A (A588T) polymorphisms of the HIF-1α gene under normoxic and hypoxic conditions show a higher transcriptional activity correlated with the overexpression of the corresponding protein than the transcriptional activity and protein expression of the wild-type sequence [27–29]. In clinical practice, the presence of these polymorphisms is associated with the development of diseases such as cancer, diabetes, and coronary disease, in which an altered HIF-1α is observed in various groups among different populations [30–32].

Currently, studies on the association between HIF-1α and LDD have not been published yet. A large-scale replication study of the association of rs17039192 in HIF-2α with knee osteoarthritis (OA) has revealed that rs17039192 in HIF-2α is not positively associated with knee OA [33]. In the present study, the association between SNPs of the HIF-1α gene and the HIF-1α expression as well as the incidence and severity of LDD was analyzed in a Chinese cohort. Significant differences were observed in the allelic and genotypic distributions of the 1790 A > G polymorphisms between the LDD cases and the control subjects. Logistic regression revealed that the 1790 AA genotype represented a protective effect against the development of LDD. To the best of our knowledge, this study is the first to report the function of HIF-1α gene SNPs in LDD. The HIF-1α 1790 A > G polymorphisms also affected the severity of LDD evaluated based on mJOA scores. The 1790 AA genotype carriers exhibited significantly lower mJOA scores than AG and GG carriers. Our study suggested that the HIF-1α 1790 A > G polymorphisms may be used as a molecular marker of the susceptibility and severity of LDD.

VEGF has an important function in physiological and pathological angiogenesis. The upregulation of VEGF expression in response to reduced oxygen stress occurs via transcriptional and post-transcriptional mechanisms [34]. A study in glioma cell has demonstrated that the binding site of HIF1 is important to induce VEGF gene expression under hypoxic conditions [35]. In visceral adipose tissues, hypoxia induces VEGF synthesis [34]. In this study, the HIF-1α gene polymorphisms in herniated lumbar intervertebral disc samples from patients with LDD were investigated. We found that 1790 A > G SNPs, not 1772C > T SNPs, significantly affected HIF-1α and VEGF expressions. VEGF and HIF-1α exhibited similar expression patterns. This result supported our hypothesis that the genetic polymorphisms of HIF-1α in LDD may occur by changing the HIF-1α and VEGF expressions.

A previous study also revealed that HIF-1α expression is strongly correlated with inflammation and angiogenesis in rheumatoid arthritis [36]. We postulated that HIF-1α may regulate the inflammation of intervertebral discs and influence the development of LDD. Our ongoing animal study focuses on the association between HIF-1α expression and inflammation level in intervertebral disc tissues.

Supporting Information

Characteristics of patients donating samples for western blot assay.

(DOC)

Click here for additional data file.

Genotypes of patients donating samples for western blot assay.

(DOC)

Click here for additional data file.

ReferencesFairbankJ (2002) Clinical importance of the intervertebral disc, or back pain for biochemists. Biochem Soc Trans30: 829-831 PubMed: 1244092712440927FreemontAJ (2009) The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxf)48: 5-10 PubMed: 18854342WilliamsFM, SambrookPN (2011) Neck and back pain and intervertebral disc degeneration: role of occupational factors. Best Pract Res Clin Rheumatol25: 69-79.10.1016/j.berh.2011.01.007 PubMed: 2166385121663851García-CosamalónJ, del ValleME, CalaviaMG, García-SuárezO, López-MuñizAet al. (2010) Intervertebral disc, sensory nerves and neurotrophins: who is who in discogenic pain?J Anat217: 1-15.10.1111/j.1469-7580.2010.01227.x PubMed: 2045652420456524WahlströmJ, BurströmL, NilssonT, JärvholmB (2012) Risk factors for hospitalization due to lumbar disc disease. Spine (Phila Pa)197637: 1334-1339 PubMed: 22281487SchoenfeldAJ, NelsonJH, BurksR, BelmontPJJr. (2011) Incidence and risk factors for lumbar degenerative disc disease in the United States military 1999-2008. Mil Med176: 1320-1324 PubMed: 2216566322165663JhawarBS, FuchsCS, ColditzGA, StampferMJ (2006) Cardiovascular risk factors for physician-diagnosed lumbar disc herniation. Spine J6: 684-691.10.1016/j.spinee.2006.04.016 PubMed: 1708819917088199KimNK, ShinDA, HanIB, YooEH, KimSHet al. (2011) The association of aggrecan gene polymorphism with the risk of intervertebral disc degeneration. Acta Neurochir (Wien)153: 129-133.10.1007/s00701-010-0831-2 PubMed: 2093648720936487JimJJ, Noponen-HietalaN, CheungKM, OttJ, KarppinenJet al. (2005) The TRP2 allele of COL9A2 is an age-dependent risk factor for the development and severity of intervertebral disc degeneration. Spine (Phila Pa)197630: 2735-2742 PubMed: 16371896RisbudMV, GuttapalliA, AlbertTJ, ShapiroIM (2005) Hypoxia activates MAPK activity in rat nucleus pulposus cells: regulation of integrin expression and cell survival. Spine (Phila Pa)197630: 2503-2509 PubMed: 16284587FujitaN, MarkovaD, AndersonDG, ChibaK, ToyamaYet al. (2012) Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1alpha activity in hypoxia. J Biol Chem287: 16975-16986.10.1074/jbc.M111.334466 PubMed: 2245165922451659ChunYS, KimMS, ParkJW (2002) Oxygen-dependent and -independent regulation of HIF-1alpha. J Korean Med Sci17: 581-588 PubMed: 1237800512378005FangJ, YanL, ShingY, MosesMA (2001) HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res61: 5731-5735 PubMed: 1147920811479208RahejaLF, GenetosDC, WongA, YellowleyCE (2011) Hypoxic regulation of mesenchymal stem cell migration: the role of RhoA and HIF-1alpha. Cell Biol Int35: 981-989.10.1042/CBI20100733 PubMed: 2157496221574962FujitaN, ChibaK, ShapiroIM, RisbudMV (2012) HIF-1alpha and HIF-2alpha degradation is differentially regulated in nucleus pulposus cells of the intervertebral disc. J Bone Miner Res27: 401-412.10.1002/jbmr.538 PubMed: 2198738521987385AgrawalA, GuttapalliA, NarayanS, AlbertTJ, ShapiroIMet al. (2007) Normoxic stabilization of HIF-1alpha drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk. Am J Physiol Cell Physiol293: C621-C631.10.1152/ajpcell.00538.2006 PubMed: 1744273417442734RisbudMV, GuttapalliA, StokesDG, HawkinsD, DanielsonKGet al. (2006) Nucleus pulposus cells express HIF-1alpha under normoxic culture conditions: a metabolic adaptation to the intervertebral disc microenvironment. J Cell Biochem98: 152-159.10.1002/jcb.20765 PubMed: 1640827916408279FuXS, ChoiE, BubleyGJ, BalkSP (2005) Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate63: 215-221.10.1002/pros.20190 PubMed: 1553874815538748VainribM, GolanM, AmirS, DangDT, DangLHet al. (2012) HIF1A C1772T polymorphism leads to HIF-1alpha mRNA overexpression in prostate cancer patients. Cancer Biol Ther13: 720-726.10.4161/cbt.20554 PubMed: 2264767922647679LiP, CaoQ, ShaoPF, CaiHZ, ZhouHet al. (2012) Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population. Asian J Androl14: 864-869.10.1038/aja.2012.101 PubMed: 2304244623042446MatsuiH, KanamoriM, IshiharaH, YudohK, NaruseYet al. (1998) Familial predisposition for lumbar degenerative disc disease. A case-control study. Spine (Phila Pa)197623: 1029-1034RevanappaKK, RajshekharV (2011) Comparison of Nurick grading system and modified Japanese Orthopaedic Association scoring system in evaluation of patients with cervical spondylotic myelopathy. Eur Spine J20: 1545-1551.10.1007/s00586-011-1773-y PubMed: 2142459121424591LeeJH, PyonJK, LeeSH, LeeYJ, KangSGet al. (2011) Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer. Int J Dermatol50: 956-960.10.1111/j.1365-4632.2010.04846.x PubMed: 2178106721781067TroutJJ, BuckwalterJA, MooreKC (1982) Ultrastructure of the human intervertebral disc: II. Cells of the nucleus pulposus. Anat Rec204: 307-314.10.1002/ar.1092040403 PubMed: 71811357181135TsukadaK, TajimaT, HoriS, MatsuuraT, JohnsonRSet al. (2012) Hypoxia-inducible factor-1 is a determinant of lobular structure and oxygen consumption in the liver. Microcirculation, 20: 385–93 PubMed: 2325246323252463HaKY, KohIJ, KirpalaniPA, KimYY, ChoYKet al. (2006) The expression of hypoxia inducible factor-1alpha and apoptosis in herniated discs. Spine (Phila Pa)197631: 1309-1313 PubMed: 16721291TanimotoK, YoshigaK, EguchiH, KaneyasuM, UkonKet al. (2003) Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis24: 1779-1783.10.1093/carcin/bgg132 PubMed: 1291995412919954CliffordSC, AstutiD, HooperL, MaxwellPH, RatcliffePJet al. (2001) The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene20: 5067-5074.10.1038/sj.onc.1204602 PubMed: 1152649311526493Nava-SalazarS, Sánchez-RodríguezEN, Mendoza-RodríguezCA, MoranC, Romero-ArauzJFet al. (2011) Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: A case-control study. BMC Res Notes4: 68.10.1186/1756-0500-4-68 PubMed: 2141422421414224PutraAC, TanimotoK, ArifinM, AntariksaB, HiyamaK (2011) Genetic variations in detoxification enzymes and HIF-1alpha in Japanese patients with COPD. Clin Respir J.HebertC, NorrisK, ParasharP, OrdRA, NikitakisNGet al. (2006) Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers. Mol Cancer5: 3.10.1186/1476-4598-5-3 PubMed: 1641225216412252KimHO, JoYH, LeeJ, LeeSS, YoonKS (2008) The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. Oncol Rep20: 1181-1187 PubMed: 1894941918949419NakajimaM, ShiD, DaiJ, TsezouA, ZhengMet al. (2012) A large-scale replication study for the association of rs17039192 in HIF-2alpha with knee osteoarthritis. J Orthop Res30: 1244-1248.10.1002/jor.22063 PubMed: 2224701922247019FusaruAM, PisoschiCG, BoldA, TaisescuC, StănescuRet al. (2012) Hypoxia induced VEGF synthesis in visceral adipose depots of obese diabetic patients. Rom J Morphol Embryol53: 903-909 PubMed: 2330301223303012DamertA, IkedaE, RisauW (1997) Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J327(2): 419-423 PubMed: 93594109359410BrouwerE, GouwAS, PosthumusMD, van LeeuwenMA, BoerboomALet al. (2009) Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis. Clin Exp Rheumatol27: 945-951 PubMed: 2014931020149310